-
公开(公告)号:FR2819509B1
公开(公告)日:2004-04-16
申请号:FR0100641
申请日:2001-01-18
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , LE DIGUARHER THIERRY , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07D213/04 , A61K31/4174 , A61K31/44
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
公开(公告)号:FR2819510B1
公开(公告)日:2003-10-31
申请号:FR0100642
申请日:2001-01-18
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , LE DIGUARHER THIERRY , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS , FAUCHERE JEAN LUC , ORTUNO JEAN CLAUDE
IPC: A61P9/00 , A61P25/00 , A61P35/00 , C07D401/12 , C07D401/14 , C07D403/12 , A61K31/55 , C07D401/04
-
公开(公告)号:AT236129T
公开(公告)日:2003-04-15
申请号:AT99402624
申请日:1999-10-22
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DOREY GILBERT , LESTAGE PIERRE , LOCKHART BRIAN
IPC: C07D215/06 , A61K31/47 , A61K31/497 , A61K31/517 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P27/12 , A61P43/00 , C07D215/20 , C07D221/20 , C07D401/06 , C07D471/10 , C07D221/00
Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).
-
34.
公开(公告)号:HK1048471A1
公开(公告)日:2003-04-04
申请号:HK03100156
申请日:2003-01-07
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DIGUARHER THIETTY LE , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07D , A61K , A61P
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
35.
公开(公告)号:EA003272B1
公开(公告)日:2003-02-27
申请号:EA199900865
申请日:1999-10-22
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DOREY GILBERT , LESTAGE PIERRE , LOCKHART BRIAN
IPC: C07D215/06 , A61K31/47 , A61K31/497 , A61K31/517 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P27/12 , A61P43/00 , C07D215/20 , C07D221/20 , C07D401/06 , C07D471/10 , C07D215/08 , C07D413/04 , A61K31/4709 , A61K31/5377
Abstract: Соединениеобщейформулы (I)где RпредставляетсобойатомводородаилигруппугдеА являетсятаким, какопределенов описании,Rи R, каждыйнезависимо, представляетсобойалкил, циклоалкил, гетероциклоалкил, необязательнозамещенныйарил, необязательнозамещенныйгетероарил, циклоалкилалкил, гетероциклоалкилалкил, необязательнозамещенныйарилалкил, необязательнозамещенныйгетероарилалкилилинеобязательнозамещенныйаминоалкилилиRи Rвместесосвязывающимихатомомуглеродаобразуютциклоалкильнуюилимоноциклическуюгетероциклическуюгруппу, замещеннуюилинезамещенную,Rпредставляетсобойатомводородаилигруппу, выбраннуюизнеобязательнозамещенногоалкила, необязательнозамещенногоалкенилаи необязательнозамещенногоалкинила, илигруппу Q или -V-Q-, где V представляетсобойгруппуалкилена, алкениленаилиалкиниленаи Q представляетсобойнеобязательнозамещеннуюциклоалкильнуюгруппу, необязательнозамещеннуюарильнуюгруппу, необязательнозамещеннуюгетероциклоалкильнуюгруппуилинеобязательнозамещеннуюгетероарильнуюгруппу,Rи Rобразуютвместесвязьиликаждыйпредставляетсобойатомводорода,R, R, Rи R, каждыйнезависимо, представляетсобойатомводорода, атомгалогена, алкильнуюгруппу, (С-С)циклоалкильнуюгруппуилигруппу -OW, где W являетсятаким, какопределенов описании.
-
公开(公告)号:BR0200114A
公开(公告)日:2002-10-22
申请号:BR0200114
申请日:2002-01-17
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DIGUARHER THIERRY LE , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07C13/24 , A61K31/015 , A61P25/28
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
公开(公告)号:CA2367306A1
公开(公告)日:2002-07-18
申请号:CA2367306
申请日:2002-01-17
Applicant: SERVIER LAB
Inventor: HICKMAN JOHN , CASARA PATRICK , PIERRE ALAIN , LE DIGUARHER THIERRY , DOREY GILBERT , GUILBAUD NICOLAS , TUCKER GORDON
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07C13/24 , A61K31/015 , C07D233/56
Abstract: L'invention concerne de nouveaux composés répondant à la formule formule (I ): dans laquelle X représente une liaison ou un groupement alkylène, CO, S(O)n, *- S(O)n-A1-, *-CO-A1-, -A1-S(O)n-A'1- et -A1-CO-A'1- dans lesquels A1 et A'1, identiques ou différents, représentent un groupement alkylène et n vaut 0, 1 ou 2, le symbole "*" représentant le point de rattachement du groupement au cycloheptène; Y représente un groupement aryle, hétéroaryle, cycloalkyle ou hétérocycloalkyle; R1, R2, R3 et R4 représentent indépendamment l'un de l'autre un atome d'hydrogène ou un groupement aryle, hétéroaryle, cycloalkyle ou hétérocycloalkyle, ou bien R1, R2, R3 et R4, pris deux à deux , forment ensemble une liaison, ou bien R1 et R2, ou R2 et R3 ou R3 et R4, pris deux à deux avec les atomes de carbone auxquels ils sont liés, forment un cycle benzénique fusion né ou un hétérocycle fusionné aromatique ou partiellement hydrogéné; T représente un groupement -CH(R5)-, -N(R5)- ou *-N(R5)CO- dans lesquels R5 représente un atome d'hydrogène ou un groupement alkyle, aryle, hétéroaryle, arylalkyle ou hétéroarylalkyle, le symbole "*" représentant le point de rattachement du groupement au cycloheptène; V représente un atome d'hydrogène ou un groupement aryle ou hétéroaryle; A2 représente un groupement [C(R6)(R'6)]p où p vaut 0, 1, 2, 3 ou 4 lorsque T représente un groupement - CH(R5)- ou *-N(R5)CO- où p vaut 1, 2, 3 ou 4 lorsque T représente un groupement -N(R5)- , et R6 et R'6, identiques ou différents, représentent un atome d'hydrogène ou un groupement alkyle, alkényle, alkynyle, aryle, hétéroaryle, hétérocycloalkyle, arylalkyle éventuellement substitué, hétéroarylalkyle, hétérocycloalkylalkyle, R9 ou alkyle substitué par un groupement R9 où R9 représente un groupement -OR5,-N(R5)(R'5), -S(O)m R5, -CON(R5)(R'5), -N(R5)COR'5, -N(R5)SO2R'5, -SO2N(R5)(R'5), -N(R5)COO(R'5), m étant égal à 0, 1 ou 2, et R'5 prenant toutes les valeurs de R5. L'invention vise également les énantiomères et diastéréoisomères des composés de formule (I), ainsi que leu rs sels -52- d'addition à un acide ou à une base pharmaceutiquement acceptable. Les composés selon l'invention sont utiles à titre de médicaments pour le traitement des maladi es cancéreuses ainsi que pour le traitement de la resténose après angioplastie ou chirurgie vasculaire, et de la neurofibromatose de type I.
-
38.
公开(公告)号:HU0200204D0
公开(公告)日:2002-03-28
申请号:HU0200204
申请日:2002-01-18
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DOREY GILBERT , GUILBAUD NICOLAS , HICKMAN JOHN , LE DIGUARHER THIERRY , PIERRE ALAIN , TUCKER GORDON
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07D207/00
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
公开(公告)号:NO20020262D0
公开(公告)日:2002-01-17
申请号:NO20020262
申请日:2002-01-17
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DIGUARHER THIERRY LE , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07C
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
-
-
-
-
-
-
-